Literature DB >> 12546871

Permeability issues in nasal drug delivery.

Priyanka Arora1, Shringi Sharma, Sanjay Garg.   

Abstract

The nasal route is one of the most permeable and highly vascularized site for drug administration ensuring rapid absorption and onset of therapeutic action. It has been potentially explored as an alternative route for drugs with poor bioavailability and for the delivery of biosensitive and high molecular weight (MW) compounds such as proteins, peptides, steroids, vaccines, and so on. This review discusses the major factors affecting the permeability of drugs or biomolecules through the nasal mucosa, including biological, formulation and device-related factors. This information could potentially help to achieve desired plasma concentrations of drugs without compromising or altering the normal physiology of the nasal cavity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12546871     DOI: 10.1016/s1359-6446(02)02452-2

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  55 in total

1.  In vitro-in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate.

Authors:  Evren Gundogdu; V Mangas-Sanjuan; Isabel Gonzalez-Alvarez; Marival Bermejo; Ercument Karasulu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-08-11       Impact factor: 2.441

2.  A Computational Study of Nasal Spray Deposition Pattern in Four Ethnic Groups.

Authors:  Jarrod A Keeler; Aniruddha Patki; Charles R Woodard; Dennis O Frank-Ito
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-08-13       Impact factor: 2.849

3.  The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model.

Authors:  Yang Guo; Beth Laube; Richard Dalby
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

4.  Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast.

Authors:  Vipra Kundoor; Richard N Dalby
Journal:  Pharm Res       Date:  2011-04-16       Impact factor: 4.200

5.  Current understanding of nasal morphology and physiology as a drug delivery target.

Authors:  Julie D Suman
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

Review 6.  Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?

Authors:  Clément Mercier; Nathalie Perek; Xavier Delavenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

Review 7.  Non-invasive delivery strategies for biologics.

Authors:  Aaron C Anselmo; Yatin Gokarn; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2018-11-30       Impact factor: 84.694

Review 8.  Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies.

Authors:  Silvia Triarico; Michele Antonio Capozza; Stefano Mastrangelo; Giorgio Attinà; Palma Maurizi; Antonio Ruggiero
Journal:  Support Care Cancer       Date:  2019-06-01       Impact factor: 3.603

9.  Comparison between intranasal dexmedetomidine and intranasal ketamine as premedication for procedural sedation in children undergoing MRI: a double-blind, randomized, placebo-controlled trial.

Authors:  Prakhar Gyanesh; Rudrashish Haldar; Divya Srivastava; Prashant Mohan Agrawal; Akhilesh Kumar Tiwari; P K Singh
Journal:  J Anesth       Date:  2013-06-26       Impact factor: 2.078

10.  Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations.

Authors:  Jing-yi Zhao; Yang Lu; Shou-ying Du; Xiao Song; Jie Bai; Yue Wang
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.